EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Exploring TMPRSS2 Drug Target to Combat Influenza and Coronavirus Infection

Krishnaprasad Baby iD, Megh Pravin Vithalkar iD, Somasish Ghosh Dastidar iD, Chiranjay Mukhopadhyay iD, Rania Hamdy iD, Sameh S M Soliman iD, Yogendra Nayak iD

Scientifica · 2025-01 · 2025 (1)

DOI: 10.1155/sci5/3687892 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Scientifica, online erschienen am 21.04.2025. Verfasst von Krishnaprasad Baby und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Indian Council of Medical Research, Manipal Academy of Higher Education, University of Sharjah.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Respiratory viral infections, including influenza and coronaviruses, present significant health risks worldwide. The recent COVID‐19 pandemic highlights the urgent need for novel and effective antiviral agents. The host cell protease, transmembrane serine protease 2 (TMPRSS2), facilitates viral pathogenesis by playing a critical role in viral invasion and disease progression. This protease is coexpressed with the viral receptors of angiotensin‐converting enzyme 2 (ACE2) for SARS‐CoV‐2 in the human respiratory tract and plays a significant role in activating viral proteins and spreading. TMPRSS2 activates the coronavirus spike (S) protein and permits membrane fusion and viral entry by cleaving the virus surface glycoproteins. It also activates the hemagglutinin (HA) protein, an enzyme necessary for the spread of influenza virus. TMPRSS2 inhibitors can reduce viral propagation and morbidity by blocking viral entry into respiratory cells and reducing viral spread, inflammation, and disease severity. This review examines the role of TMPRSS2 in viral replication and pathogenicity. It also offers potential avenues to develop targeted antivirals to inhibit TMPRSS2 function, suggesting a possible focus on targeted antiviral development. Ultimately, the review seeks to contribute to improving public health outcomes related to these viral infections.

Schlagwörter

Stichwörter der Autor:innen

COVID-19 treatmentSARS-CoV-2antiviral therapycoronavirushost proteasesinfluenza virusprotease inhibitionpublic health strategiestTMPRSS2viral pathogenesis

Autor:innen und Institutionen

  • Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.
  • Centre for Molecular Neurosciences, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.
  • Manipal Institute of Virology, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.
  • Department of Microbiology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.
  • Centre for Emerging and Tropical Diseases, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.
  • Research Institute for Science and Engineering (RISE), University of Sharjah, Sharjah 27272, UAE.

ORCID-Profile: Krishnaprasad Baby, Megh Pravin Vithalkar, Somasish Ghosh Dastidar, Chiranjay Mukhopadhyay, Rania Hamdy, Sameh S M Soliman, Yogendra Nayak

Förderung

  • Indian Council of Medical Research
  • Manipal Academy of Higher Education
  • University of Sharjah

Zitieren

APA

Baby, K., Vithalkar, M. P., Dastidar, S. G., Mukhopadhyay, C., Hamdy, R., Soliman, S. S. M., & Nayak, Y. (2025). Exploring TMPRSS2 Drug Target to Combat Influenza and Coronavirus Infection. Scientifica, 2025(1). https://doi.org/10.1155/sci5/3687892

Vancouver

Baby K, Vithalkar MP, Dastidar SG, Mukhopadhyay C, Hamdy R, Soliman SSM, et al. Exploring TMPRSS2 Drug Target to Combat Influenza and Coronavirus Infection. Scientifica. 2025;2025(1). doi:10.1155/sci5/3687892

BibTeX
@article{Baby2025,
  author = {Baby, Krishnaprasad and Vithalkar, Megh Pravin and Dastidar, Somasish Ghosh and Mukhopadhyay, Chiranjay and Hamdy, Rania and Soliman, Sameh S M and Nayak, Yogendra},
  title = {Exploring TMPRSS2 Drug Target to Combat Influenza and Coronavirus Infection},
  journal = {Scientifica},
  year = {2025},
  volume = {2025},
  number = {1},
  doi = {10.1155/sci5/3687892}
}
Kostenlos starten →